In this 2023 review, Yaku and Nakagawa explore the role of NAD+ precursors, such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), in human health and disease. They discuss how NAD+ levels decline with age and in various diseases, and how supplementation with these precursors can restore NAD+ levels, potentially
